Glycochenodeoxycholic acid sodium salt ergolide mesylate is a selective estrogen receptor

is a selective estrogen receptor beta (ERβ) agonist that was developed for the treatment of benign prostatic hyperplasia

and invasion of Stat3-dependent tumor cells

followed by caspase 9 and 3 activation

but it also moderates inhibition of dendritic cell differentiation and decreases the number of tumor vessels in glioma models

presumably by reducing the rate of formation of bicarbonate ions with subsequent reduction in sodium and fluid transport

Glycochenodeoxycholic acid sodium salt ergolide mesylate is a selective estrogen receptorGlycochenodeoxycholic acid sodium salt (Chenodeoxycholylglycine sodium salt) is a bile acid formed in the liver from chenodeoxycholate and glycine. It acts as a detergent to solubilize fats for absorption and is itself absorbed. Glycochenodeoxycholic acid sodium salt (Chenodeoxycholylglycine sodium salt) induces hepatocyte apoptosis. Product information CAS Number: 16564 43 5 Molecular Weight: 471. 61 Formula: C26H42NNaO5 Synonym: